German IT Stock News

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...

It is hard to get excited after looking at CTS Eventim KGaA's (ETR:EVD) recent performance, when its stock has declined...

Münchener Rückversicherungs-Gesellschaft in München (XTRA:MUV2) has just reported the latest figures from its share buyback program, revealing over 79,000 shares repurchased between October 17 and October 27. This ongoing buyback attracts the attention of investors who are curious about what it signals for the company's valuation. See our latest analysis for Münchener Rückversicherungs-Gesellschaft in München. Momentum for Münchener Rückversicherungs-Gesellschaft in München has slowed a bit...

It's been a sad week for PUMA SE ( ETR:PUM ), who've watched their investment drop 16% to €18.42 in the week since the...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Kontron fair value estimate is €30.85 Kontron's €22.68 share...

thyssenkrupp nucera AG & Co. KGaA ( ETR:NCH2 ), is not the largest company out there, but it saw significant share...

It's shaping up to be a tough period for Knorr-Bremse AG ( ETR:KBX ), which a week ago released some disappointing...

To the annoyance of some shareholders, Gerresheimer AG ( ETR:GXI ) shares are down a considerable 27% in the last...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

HelloFresh SE ( ETR:HFG ) shareholders are probably feeling a little disappointed, since its shares fell 7.1% to €7.02...

Surteco Group (XTRA:SUR) remains unprofitable, recording losses that have increased at an average annual rate of 41.1% over the past five years. Despite revenue growth forecasts of 3.3% per year, which lag behind the broader German market’s 6.1%, analysts expect earnings to make a turnaround, with robust projected growth of 58.23% per year and a return to profitability anticipated within the next three years. With shares trading at €12.4, a discount to the estimated fair value of €18.61, and...

Vossloh (XTRA:VOS) released earnings showing higher sales for the first nine months of the year. However, net income and earnings per share have slipped from last year’s figures, drawing attention from investors. See our latest analysis for Vossloh. After an impressive rally saw Vossloh’s share price surge more than 83% year-to-date, momentum has cooled as investors weighed the latest earnings and valuation concerns highlighted by a recent analyst downgrade. Still, long-term holders have...

Befesa (XTRA:BFSA) posted a robust set of figures, with earnings forecast to grow at 11.1% annually and revenues expected to rise 6.5% per year, both outpacing the German market's 6.1% growth rate. Net profit margins improved to 5.8% from last year's 4.9%, and the most recent year delivered a 22.7% increase in earnings after a five-year average annual decline of 4.9%. Investors are likely to see the company's return to earnings growth and better margins, coupled with attractive valuation, as...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

With a price-to-earnings (or "P/E") ratio of 15.1x Grenke AG ( ETR:GLJ ) may be sending bullish signals at the moment...

medondo holding AG ( ETR:AMI ) is possibly approaching a major achievement in its business, so we would like to shine...

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

AlzChem Group (XTRA:ACT) posted annual earnings growth of 25%, well above its five-year average of 22.9% per year and comfortably outpacing the German market's current 16.7% rate. Net profit margins reached 10.2%, up from 8.4% last year. The company's strong forecasts call for 18.5% annual earnings growth ahead. With all reward indicators showing positive trends and no identified risks, investors are likely to view these results as robust. However, the elevated price-to-earnings ratio...

To the annoyance of some shareholders, KAP AG ( ETR:IUR ) shares are down a considerable 37% in the last month, which...

Wondering if Merck KGaA's recent price dip is actually presenting a hidden value opportunity? You’re not alone. Knowing how to spot these moments is what separates the casual observer from the informed investor. It’s been a choppy ride lately, with the stock down 1.4% over the last week, 5.8% over the past month, and a notable 19.2% slide so far this year. These moves haven’t happened in a vacuum. Shifts in the German pharmaceutical sector and regulatory changes have been stirring up...

AIXTRON (XTRA:AIXA) reported earnings growth that continues to outpace the broader German market, with forecasts calling for an 18.4% increase in earnings per year and a 9.4% rise in revenue. Both of these figures are ahead of the market’s 6.1% growth expectation. Over the past five years, the company’s earnings have grown at a robust 19.4% annualized rate, though the most recent net profit margin fell to 17.2% from last year’s 19.6%. Investors are watching closely as margins compress, but...

PSI Software (XTRA:PSAN) remains unprofitable, with losses increasing at an annual rate of 57.1% over the last five years. Despite ongoing negative net margins, the company’s top line paints a different story. Revenues are forecast to jump 9.6% per year, outpacing the German market, and earnings are projected to expand at 54.62% per year with a return to profitability expected within three years. Investors eye these growth forecasts as well as the company’s valuation, which currently sits...

KION GROUP (XTRA:KGX) saw earnings decline by 6% per year over the past five years, with current net profit margins at 2% versus 2.9% a year ago. Looking forward, earnings are forecast to grow at a rapid 37.74% annually over the next three years, which is more than double the German market’s expected 16.7% per year. However, revenue projections of 5.6% trail the broader market. Investors are likely to weigh the recent contraction in profit margins and the multi-year decline in earnings...